Genomics is moving into mainstream healthcare. But is the underlying infrastructure ready?
As genomic testing scales, interoperability is becoming critical. Orders, patient data, genomic data, analysis tools, reports, and EMRs all need to work together using the language of healthcare: FHIR.
The challenge is that many genomic workflows still rely on:
👉 point-to-point integrations
👉 manual handoffs
👉 disconnected systems
👉 ad hoc workarounds
That may work today, but what happens when genomic ordering becomes embedded directly into EMRs and routine clinical care? Labs without scalable interoperability risk creating a major operational bottleneck:
⏰ slower onboarding of new referrers
💸 increased administrative overhead
📉 reduced scalability
⛓️💥fragmented data flows
💰growing integration costs
❌ and ultimately constraints on capacity, growth and revenue
At Genomical, we built our GIMS platform using FHIR from the outset. When electronic genomic orders begin flowing directly from healthcare systems, Genomical workflows are already designed to support them natively from order through analysis to reporting.
That means less custom integration work, more scalable operations, and infrastructure designed for the future of precision medicine.
Genomics powered by FHIR 🔥

